Placebo analgesia and beyond: A melting pot of concepts and ideas for neuroscience

Current Opinion in Anaesthesiology

Volumn 24, Issue 5, 2011, Pages 540-544

  Carlino, Elisa ^a   Pollo, Antonella ^a   Benedetti, Fabrizio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

cholecystokinin; dopamine; endogenous opioids; learning; placebo; prefrontal cortex; serotonin

Indexed keywords

ACETYLSALICYLIC ACID; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; DOPAMINE; MORPHINE; NALOXONE; PENTAGASTRIN; PLACEBO; REMIFENTANIL; SEROTONIN; TRYPTOPHAN HYDROXYLASE 2;

AMYGDALOID NUCLEUS; ANALGESIA; ANALGESIC ACTIVITY; ANTERIOR CINGULATE; ANXIETY DISORDER; CHRONIC PAIN; COGNITION; CONTROLLED CLINICAL TRIAL (TOPIC); ELECTROENCEPHALOGRAM; EVOKED RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GUSTATORY CORTEX; HOT PLATE TEST; HUMAN; LASER; LEARNING; MEMORY; NEUROPATHIC PAIN; NEUROSCIENCE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; PERIAQUEDUCTAL GRAY MATTER; PLACEBO EFFECT; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; REWARD; TRANSCRANIAL MAGNETIC STIMULATION;

ANALGESIA; ANXIETY; HUMANS; MEMORY; NEUROSCIENCES; PAIN; PAIN MANAGEMENT; PARKINSON DISEASE; PLACEBO EFFECT; PREFRONTAL CORTEX; RECEPTORS, OPIOID;

EID: 80052652493     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328349d0c2     Document Type: Review

References (49)

1. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008; 59:195-206. (Pubitemid 352033692)
2. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375:686-695.
3. Tracey I. Getting the pain you expected: mechanisms of placebo, nocebo and reappraisal effects in humans. Nat Med 2010; 16:1277-1283.
4. Benedetti F, Carlino E, Pollo A. How placebos change the patient's brain. Neuropsychopharmacol Rev 2011; 36:339-354.
5. De la Fuente-Fernandez R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 2001; 293:1164-1166. (Pubitemid 32758101)
6. De la Fuente-Fernandez R, Phillips AG, Zamburlini M, et al. Dopamine release in human ventral striatum and expectation of reward. Behav Brain Res 2002; 136:359-363. (Pubitemid 35333251)
7. De la Fuente-Fernandez R. The placebo-reward hypothesis: dopamine and the placebo effect. Parkinsonism Relat Disord 2009; 15(S3):S72-S74.
8. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. J Neurosci 2003; 23:4315-4323. (Pubitemid 36958452)
9. Pacheco-Lopez G, Engler H, Niemi MB, Schedlowski M. Expectations and associations tha heal: immunomodulatory placebo effects and its neurobiology. Brain Behav Immun 2006; 20:430-446. (Pubitemid 44175800)
10. Schedlowski M, Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain Behav Immun 2010; 24:176-185.
11. Leuchter AF, Cook IA, Witte EA, et al. Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159:122-129. (Pubitemid 41070737)
12. Mayberg HS, Silva JA, Brannan SK, et al. The functional neuroanatomy of the placebo effect. Am J Psychiatry 2002; 159:728-737. (Pubitemid 34465045)
13. Leuchter AF, McCracken JT, Hunter AM, et al. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol 2009; 29:372-437.
14. Vase L, Robinson ME, Verne GN, Price DD. Increase placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005; 115:338-347. (Pubitemid 40725290)
15. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 2007; 20:435-439. (Pubitemid 47415134)
16. Van Laarthover AIM, Vogelaar M, Wildser-Smith OH, et al. Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain 2011; 152:1486-1494.
17. Pavlov I. Conditioned reflexes: an investigation of the physiological activity of the cerebral cortex. Oxford University Press, Cambridge 1927.
18. Morton DL, Brown CA, Watson A, et al. Cognitive changes as a result of a single exposure to placebo. Neuropsychologia 2010; 48:1958-1964.
19. Colloca L, Tinazzi M, Recchia S, et al. Learning potentiates neurophysio-logical and behavioral placebo analgesic responses. Pain 2009; 139:306-314.
20. Watson A, El-Deredy W, Bentley DE, et al. Categories of placebo response in the absence of site-specific expectation of analgesia. Pain 2006; 126:115-122. (Pubitemid 44751959)
21. Colloca L, Petrovic P, Wager TD, et al. How the number of learning trials affects placebo and nocebo responses. Pain 2010; 151:430-439.
22. Andre-Obadia N, Magnin M, Garcia-Larrea L. On the importance of placebo timing in rTMS studies for pain relief. Pain 2011; 152:1233-1237.
23. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 1999; 19:484-494. (Pubitemid 29028987)
24. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain 2006; 124:126-133. (Pubitemid 44176203)
25. Eippert F, Bingel U, Schoell ED, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63:533-543.
26. Benedetti F, Amanzio M, Thoen W. Disruption of opioid-induced placebo responses by activation of cholecystokinin type-2 receptors. Psychopharmacology 2011; 213:791-797.
27. Benedetti F, Amanzio M, Maggi G. Potentiation of placebo analgesia by proglumide Lancet 1995; 346:1231.
28. Stern J, Candia V, Porchet RI, et al. Placebo-mediated, naloxone-sensitive suggestibility of short-term memory performance. Neurobiol Learn Mem 2011; 95:326-334.
29. Guo JY, Wang JY, Luo F. Dissection of placebo analgesia in mice: the conditions for activation of opioid and nonopioid systems. J Psychopharmacol 2009; 24:1561-1567.
30. Petrovic P, Kalso E, Petersson KM, et al. A prefrontal nonopioid mechanism of placebo analgesia. Pain 2010; 150:59-65.
31. Wager RD, Roy M. Separate mechanisms for placebo and opiate analgesia? Pain 2010; 150:8-9.
32. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imagine a shared neuronal network. Science 2002; 295:1737-1740. (Pubitemid 34202913)
33. Petrovic P, Dietrich T, Fransson P, et al. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 2005; 46:957-969. (Pubitemid 40805354)
34. Scott DJ, Stohler CS, Egnatuk CM, et al. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron 2007; 55:325-336. (Pubitemid 47048908)
35. Scott DJ, Stohler CS, Egnatuk CM, et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch gen Psychiatry 2008; 65:220-231. (Pubitemid 351214321)
36. Strafella AP, Ko JH, Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage 2006; 31:1666-1672.
37. Lidstone SC, Schulzer M, Dinelle K, et al. Effects of expectation on placeboinduced dopamine release in Parkinson disease. Arch Gen Psychiatry 2010; 67:857-865.
38. Furmark T, Appel L, Henningsson S, et al. A link between serotonin-related gene polymorphisms, amygdale activity, and placebo-induced relief from social anxiety. J Neurosci 2008; 28:13066-13074.
39. Wager TD, Rilling JK, Smith EE, et al. Placebo induced changes infMRI in the anticipation and experience of pain. Science 2004; 303:1162-1167. (Pubitemid 38233575)
40. Zubieta JK, Bueller JA, Jackson LR et al. Placebo effects mediated by endogenous opioid activity on opioid receptors J Neurosci 2005; 25:7754-7762. (Pubitemid 41208646)
41. Bingel U, Wanigasekera V, Wiech K et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3:70ra14.
42. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety and Parkinson's disease. Lancet Neurol 2004; 3:679-684. (Pubitemid 39370638)
43. Benedetti F, Carlino E, Pollo A. The open-hidden paradigm. Clin Pharmacol Ther. (in press).
44. Gollub RL, Kong J. For placebo effects in medicine, seeing is believing. Sci Transl Med 2011; 3:70ps5.
45. Lui F, Colloca L, Duzzi D, et al. Neural bases of conditioned placebo analgesia. Pain 2010; 151:816-824.
46. Lu HC, Hsieh JC, Lu CL, et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: A 3T-fMRI study. Pain 2010; 148:75-83.
47. Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of pain activity during anticipation and pain experience. J Neurosci 2011; 31:439-452.
48. Krummenacher P, Candia V, Folkers G, et al. Prefrontal cortex modulates placebo analgesia. Pain 2010; 148:368-374.
49. Benedetti F, Arduino C, Costa S, et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 2006; 121:133-144. (Pubitemid 43261640)